open access

Vol 10, Supp. C (2014)
Case report
Published online: 2014-08-29
Get Citation

Sequential treatment of a patient with prostate cancer using radiation, hormonal and chemotherapy

Magdalena Krakowska, Agnieszka Zięba, Urszula Czernek

open access

Vol 10, Supp. C (2014)
CASE REPORT
Published online: 2014-08-29

Abstract

This article presents a patient with prostate cancer treated for 11 years. Primarily LHRH analogue was administered and an antiandrogen was added after 2 years. In 2009 the patient received prostate radiotherapy and then palliative irradiation of metastatic lesions in the bones. After finding castration-resistant prostate cancer, chemotherapy (docetaxel) was administered. Since February 2012 the patient has been receiving abiraterone acetate achieving marker and clinical remission as well as radiological stabilization. No significant deterioration in performance status (ECOG PS 0–1) is observed, moreover reduction in pain has been noted. The patient remains professionally active.

Abstract

This article presents a patient with prostate cancer treated for 11 years. Primarily LHRH analogue was administered and an antiandrogen was added after 2 years. In 2009 the patient received prostate radiotherapy and then palliative irradiation of metastatic lesions in the bones. After finding castration-resistant prostate cancer, chemotherapy (docetaxel) was administered. Since February 2012 the patient has been receiving abiraterone acetate achieving marker and clinical remission as well as radiological stabilization. No significant deterioration in performance status (ECOG PS 0–1) is observed, moreover reduction in pain has been noted. The patient remains professionally active.

Get Citation

Keywords

prostate cancer, castration resistance, abiraterone acetate

About this article
Title

Sequential treatment of a patient with prostate cancer using radiation, hormonal and chemotherapy

Journal

Oncology in Clinical Practice

Issue

Vol 10, Supp. C (2014)

Article type

Case report

Pages

16-18

Published online

2014-08-29

Keywords

prostate cancer
castration resistance
abiraterone acetate

Authors

Magdalena Krakowska
Agnieszka Zięba
Urszula Czernek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl